Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2015
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 06 Nov 2015 New trial record